Autoimmune Disease Diagnostics Market Research Report Information by Disease Type (Systemic Autoimmune Disease and Others), Localized Autoimmune Disease (Dot Blot, and Line Blot), End-User (Hospitals, Diagnostics Centers and Others ) - Forecast till 2032

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Autoimmune Disease Diagnostics Market, by Disease Type

6.1 Introduction

6.2 Systemic Autoimmune Disease

6.2.1 Psoriasis

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

6.2.2 Multiple Sclerosis

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

6.2.3 Rheumatoid Arthritis

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

6.2.4 Systemic Lupus Erythematosus (SLE)

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

6.2.5 Others

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

6.3 Localized Autoimmune Disease

6.3.1 Inflammatory Bowel Disease

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

6.3.2 Thyroid

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

6.3.3 Type 1 Diabetes

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

6.3.4 Others

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

Chapter 7. Global Autoimmune Disease DiagnosticsMarket, by Test Type

7.1 Introduction

7.2 Western Blotting

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

7.3 Enzyme-linked Immunosorbent Assay (ELISA)

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

7.4 Double Immune Diffusion

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

7.5 Dot Blot

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

7.6 Counter Immune-electrophoresis

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

7.7 Line Blot

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

7.8 Immunofluorescence assays (IFA)

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

7.9 Multiplex Immunoassay

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

7.10 Agglutination

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

7.11 Others

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

Chapter 8. Global Autoimmune Disease DiagnosticsMarket, by By End-User

8.1 Introduction

8.2 Hospitals

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

8.3 Diagnostics Centers

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

8.4 Research Laboratories

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

8.5 Others

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

Chapter 9. Global Autoimmune Disease Diagnostics Market, by Region

9.1 Introduction

9.2 Americas

9.2.1 North America

9.2.1.1 US

9.2.1.2 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 UK

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia-Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 South Korea

9.4.6 Rest of Asia-Pacific

9.5 Middle East & Africa

9.5.1 Middle East

9.5.2 Africa

Chapter 10. Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

Chapter 11. Company Profiles

11.1 Abbott

11.1.1 Company Overview

11.1.2 Product Overview

11.1.3 Financials Overview

11.1.4 Key Developments

11.1.5 SWOT Analysis

11.2 Siemens Healthcare Private Limited

11.2.1 Company Overview

11.2.2 Product Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 BioMérieux SA

11.3.1 Company Overview

11.3.2 Product Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 Bio-rad Laboratories.

11.4.1 Company Overview

11.4.2 Technologys/Business Segment Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 Beckman Coulter, Inc.

11.5.1 Company Overview

11.5.2 Product Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.5.5 SWOT Analysis

11.6 AstraZeneca

11.6.1 Company Overview

11.6.2 Product Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.6.5 SWOT Analysis

11.7 EUROIMMUN AG

11.7.1 Overview

11.7.2 Product Overview

11.7.3 Financial Overview

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 F. Hoffmann-la Roche

11.8.1 Overview

11.8.2 Product/ Technology Overview

11.8.3 Financials

11.8.4 Key Developments

11.8.5 SWOT Analysis

11.9 Inova Diagnostics, Inc.

11.9.1 Overview

11.9.2 Product Overview

11.9.3 Financials

11.9.4 Key Developments

11.9.5 SWOT Analysis

11.10 Myriad Genetics, Inc.

11.10.1 Overview

11.10.2 Product Overview

11.10.3 Financials

11.10.4 Key Developments

11.10.5 SWOT Analysis

11.11 Thermo Fisher Scientific

11.11.1 Overview

11.11.2 Product Overview

11.11.3 Financials

11.11.4 Key Developments

11.11.5 SWOT Analysis

11.12 Trinity Biotech Plc.

11.12.1 Overview

11.12.2 Product Overview

11.12.3 Financials

11.12.4 Key Developments

11.12.5 SWOT Analysis

11.13 Hemagen Diagnostics, Inc.

11.13.1 Overview

11.13.2 Product Overview

11.13.3 Financials

11.13.4 Key Developments

11.13.5 SWOT Analysis

Chapter 12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s Viewpoint

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Predictions for the Autoimmune Disease DiagnosticsIndustry

Chapter 13. Appendix

LIST OF TABLES

Table 1 Global Autoimmune Disease Diagnostics Market Synopsis, 2023-2030

Table 2 Global Autoimmune Disease Diagnostics Market Estimates and Forecast, 2023-2030 (USD Million)

Table 3 Global Autoimmune Disease Diagnostics Market, by Region, 2023-2030 (USD Million)

Table 4 Global Autoimmune Disease DiagnosticsMarket, by Disease Type, 2023-2030 (USD Million)

Table 5 Global Autoimmune Disease DiagnosticsMarket, by Usability, 2023-2030 (USD Million)

Table 6 Global Autoimmune Disease DiagnosticsMarket, by End-User, 2023-2030 (USD Million)

Table 7 North America: Autoimmune Disease DiagnosticsMarket, by Disease Type, 2023-2030 (USD Million)

Table 8 North America: Autoimmune Disease DiagnosticsMarket, by Test Type, 2023-2030 (USD Million)

Table 9 North America: Autoimmune Disease DiagnosticsMarket, by End-User, 2023-2030 (USD Million)

Table 10 US: Autoimmune Disease Diagnostics Market, by Disease Type, 2023-2030 (USD Million)

Table 11 US: Autoimmune Disease Diagnostics Market, by Test Type, 2023-2030 (USD Million)

Table 12 US: Autoimmune Disease Diagnostics Market, by End-User, 2023-2030 (USD Million)

Table 13 Canada: Autoimmune Disease Diagnostics Market,by Disease Type, 2023-2030 (USD Million)

Table 14 Canada: Autoimmune Disease Diagnostics Market, by Test Type, 2023-2030 (USD Million)

Table 15 Canada: Autoimmune Disease DiagnosticsMarket, by End-User, 2023-2030 (USD Million)

Table 16 South America: Autoimmune Disease Diagnostics Market, by Disease Type, 2023-2030 (USD Million)

Table 17 South America: Autoimmune Disease Diagnostics Market, by Usability, 2023-2030 (USD Million)

Table 18 South America: Autoimmune Disease Diagnostics Market, by End-User, 2023-2030 (USD Million)

Table 19 Europe: Autoimmune Disease DiagnosticsMarket, by Disease Type, 2023-2030 (USD Million)

Table 20 Europe: Autoimmune Disease Diagnostics Market, by Test Type, 2023-2030 (USD Million)

Table 21 Europe: Autoimmune Disease Diagnostics Market, by End-User, 2023-2030 (USD Million)

Table 22 Western Europe: Autoimmune Disease Diagnostics Market, by Disease Type, 2023-2030 (USD Million)

Table 23 Western Europe: Autoimmune Disease Diagnostics Market, by Test Type, 2023-2030 (USD Million)

Table 24 Western Europe: Autoimmune Disease Diagnostics Market, by End-User, 2023-2030 (USD Million)

Table 25 Eastern Europe: Autoimmune Disease Diagnostics Market, by Disease Type, 2023-2030 (USD Million)

Table 26 Eastern Europe: Autoimmune Disease Diagnostics Market, by Test Type, 2023-2030 (USD Million)

Table 27 Eastern Europe: Autoimmune Disease Diagnostics Market, by End-User, 2023-2030 (USD Million)

Table 28 Asia-Pacific: Autoimmune Disease Diagnostics Market, by Disease Type, 2023-2030 (USD Million)

Table 29 Asia-Pacific: Autoimmune Disease Diagnostics Market, by Test Type, 2023-2030 (USD

Million)

Table 30 Asia-Pacific: Autoimmune Disease Diagnostics Market, by End-User, 2023-2030 (USD

Million)

Table 31 Middle East & Africa: Autoimmune Disease Diagnostics Market, by Disease Type, 2023-2030 (USD Million)

Table 32 Middle East & Africa: Autoimmune Disease Diagnostics Market, by Test Type, 2023-2030 (USD Million)

Table 33 Middle East & Africa: Autoimmune Disease Diagnostics Market, by End-User, 2023-2030 (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Autoimmune Disease Diagnostics Market

Figure 3 Segmentation Market Dynamics for Global Autoimmune Disease Diagnostics Market

Figure 4 Global Autoimmune Disease Diagnostics Market Share, by Disease Type, 2023

Figure 5 Global Autoimmune Disease Diagnostics Market Share, by Test Type, 2023

Figure 6 Global Autoimmune Disease Diagnostics Market Share, by End-User, 2023

Figure 7 Global Autoimmune Disease Diagnostics Market Share, by Region, 2023

Figure 8 North America: Autoimmune Disease Diagnostics Market Share, by Country, 2023

Figure 9 Europe: Autoimmune Disease Diagnostics Market Share, by Country, 2023

Figure 10 Asia-Pacific: Autoimmune Disease Diagnostics Market Share, by Country, 2023

Figure 11 Middle East & Africa: Autoimmune Disease Diagnostics Market Share, by Country, 2023

Figure 12 Global Autoimmune Disease Diagnostics Market: Company Share Analysis, 2023 (%)

Figure 13 Abbott: Key Financials

Figure 14 Abbott: Segmental Revenue

Figure 15 Abbott: Geographical Revenue

Figure 16 Siemens Healthcare Private Limited: Key Financials

Figure 17 Siemens Healthcare Private Limited: Segmental Revenue

Figure 18 Siemens Healthcare Private Limited: Geographical Revenue

Figure 19 BioMérieux SA: Key Financials

Figure 20 BioMérieux SA: Segmental Revenue

Figure 21 BioMérieux SA: Geographical Revenue

Figure 22 Bio-rad Laboratories. : Key Financials

Figure 23 Bio-rad Laboratories. : Segmental Revenue

Figure 24 Bio-rad Laboratories. : Geographical Revenue

Figure 25 Beckman Coulter, Inc.: Key Financials

Figure 26 Beckman Coulter, Inc.: Segmental Revenue

Figure 27 Beckman Coulter, Inc.. Geographical Revenue

Figure 28 AstraZeneca: Key Financials

Figure 29 AstraZeneca: Segmental Revenue

Figure 30 AstraZeneca: Geographical Revenue

Figure 31 EUROIMMUN AG: Key Financials

Figure 32 EUROIMMUN AG: Segmental Revenue

Figure 33 EUROIMMUN AG: Geographical Revenue

Figure 34 F. Hoffmann-la Roche: Key Financials

Figure 35 F. Hoffmann-la Roche: Segmental Revenue

Figure 36 F. Hoffmann-la Roche: Geographical Revenue

Figure 37 Inova Diagnostics, Inc.: Key Financials

Figure 38 Inova Diagnostics, Inc.: Segmental Revenue

Figure 39 Inova Diagnostics, Inc.: Geographical Revenue

Figure 40 Myriad Genetics, Inc.: Key Financials

Figure 41 Myriad Genetics, Inc.: Segmental Revenue

Figure 42 Myriad Genetics, Inc.: Geographical Revenue

Figure 43 Thermo Fisher Scientific: Segmental Revenue

Figure 44 Thermo Fisher Scientific: Geographical Revenue

Figure 45 Thermo Fisher Scientific Corporation: Key Financials

Figure 46 Trinity Biotech Plc.: Key Financials

Figure 47 Trinity Biotech Plc.: Segmental Revenue

Figure 48 Trinity Biotech Plc.: Geographical Revenue

Figure 49 Hemagen Diagnostics, Inc.: Key Financials

Figure 50 Hemagen Diagnostics, Inc.: Segmental Revenue

Figure 51 Hemagen Diagnostics, Inc.: Geographical Revenue